| Gender (Female) |
10 |
10 |
N/A |
| Age (yr) |
16 ± 3.3 |
16.5 ± 2.4 |
0.56 |
| Weight (kg) |
65.3 ± 18.4 |
70.2 ± 23.2 |
0.47 |
| Height (cm) |
158 ±11.3 |
163.5 ± 9.75 |
0.11 |
| Height SDS |
−0.88 ± 1.19 |
−0.22 ± 1.38 |
0.12 |
| Body Mass Index (BMI) (kg/m2) |
26.5 ± 8.7 |
26.2 ± 8.6 |
0.93 |
| BMI SDS |
0.81 ± 1.17 |
0.73 ± 1.18 |
0.82 |
| Body surface area (m2) |
1.68 ± 0.26 |
1.77 ± 0.31 |
0.30 |
| Waist circumference (cm) |
81.5 ± 14.9 |
83.5 ± 16.5 |
0.69 |
| Waist-to-height ratio |
0.52 ± 0.11 |
0.51 ± 0.10 |
0.78 |
| Heart rate (beats per minute) |
74.3 ±15.8 |
70.6 ± 9.8 |
0.42 |
| Systolic blood pressure (mm Hg) |
113 ± 12.6 |
113.5 ± 10.2 |
0.89 |
| Diastolic blood pressure (mm Hg) |
62 ± 11.3 |
61.4 ± 8.3 |
0.86 |
| Total Cholesterol (mg/dL) |
158.7 ± 32.4 |
149.9 ± 28.0 |
0.36 |
| LDL (mg/dL) |
86.3 ± 19.7 |
89.1 ± 27.3 |
0.71 |
| Triglycerides (mg/dL) |
74.3 ±33.9 |
119.8 ± 94.9 |
0.02 |
| HDL (mg/dL) |
55.1 ± 12.4 |
47.0 ± 10.8 |
0.03 |
|
TABLE 1B. Clinical Characteristics of Adolescents and Young Adults with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency (N = 28; data presented as mean ± SD). |
| Glucocorticoid dose in hydrocortisone equivalents (mg/m2/day) |
19.5 ± 5.5 |
|
|
| Fludrocortisone dose (mg/day) |
0.1 ± 0.06 |
|
|
| 17-OHP (ng/dL) |
5677.3 ± 7803.9 |
|
|
| Androstenedione (ng/dL) |
198.7 ± 200.4 |
|
|
| DHEAS (mcg/dL) |
27.9 ± 39.9 (females) |
45.2 ± 26.2 (males) |
|
| Total testosterone (ng/dL) |
21.4 ± 14.2 (females) |
412.4 ± 225.6 (males) |
|
| Free testosterone (pg/mL) |
4.1 ± 3.7 (females) |
63.6 ± 34.8 (males) |
|
